Rosuvast 5 / 10 / 20 / 40

Array
(
    [ID] => 1358
    [post_author] => 16
    [post_date] => 2012-06-26 16:06:19
    [post_date_gmt] => 2012-06-26 16:06:19
    [post_content] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:

Rosuvast 5 mg: Rosuvastatina 5 mg
Rosuvast 10 mg: Rosuvastatina 10 mg
Rosuvast 20 mg: Rosuvastatina 20 mg
Rosuvast 40 mg: Rosuvastatina 40 mg
Acción Terapéutica:
Inhibidor de la HMG-CoA reductasa.
Indicaciones:

 	
Hiperlipidemia y dislipidemia mixta.
 	
Pacientes pediátricos de 10 a 17 años de edad con hipercolesterolemia familiar heterocigótica.
 	
Hipertrigliceridemia.
 	
Disbetalipoproteinemia primeria ( Hiperlipoproteinemia tipo III).
 	
Hipercolesterolemia familiar homocigota.
 	
Retraso de la progresión de la aterosclerosis.
 	
Prevención de eventos cardiovasculares.

Presentaciones:
Rosuvast 5 mg: Envases por 28, 30 y 60 comp. rec.
Rosuvast 10 mg: Envases por 28, 30, 56 y 60 comp. rec.
Rosuvast 20 mg:Envases por 28, 30 y 60 comp. rec.
Rosuvast 40 mg: Envases por 28 y 30 comp. rec.
    [post_title] => Rosuvast 5 / 10 / 20 / 40
    [post_excerpt] => Inhibidor de la HMG-CoA reductasa. Código ATC: C10A A07.
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => rosuvast
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2022-11-22 12:25:17
    [post_modified_gmt] => 2022-11-22 15:25:17
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum//?post_type=productos&p=1358
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19039
                    [post_author] => 17
                    [post_date] => 2021-07-14 09:52:12
                    [post_date_gmt] => 2021-07-14 12:52:12
                    [post_content] => 
                    [post_title] => ROSUVAST-informacion-para-el-paciente_
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => rosuvast-informacion-para-el-paciente_-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2021-07-14 09:52:12
                    [post_modified_gmt] => 2021-07-14 12:52:12
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2021/07/ROSUVAST-informacion-para-el-paciente_.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19040
                    [post_author] => 17
                    [post_date] => 2021-07-14 09:53:10
                    [post_date_gmt] => 2021-07-14 12:53:10
                    [post_content] => 
                    [post_title] => ROSUVAST-prospecto
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => rosuvast-prospecto
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2021-07-14 09:53:10
                    [post_modified_gmt] => 2021-07-14 12:53:10
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2021/07/ROSUVAST-prospecto.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 2803
                    [post_author] => 16
                    [post_date] => 2012-07-26 19:14:10
                    [post_date_gmt] => 2012-07-26 19:14:10
                    [post_content] => 
                    [post_title] => img_rosuvast.jpg
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => open
                    [post_password] => 
                    [post_name] => img_rosuvast-jpg
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2012-07-26 19:14:10
                    [post_modified_gmt] => 2012-07-26 19:14:10
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => 
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/jpeg
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Rosuvast
        )

    [principio_activo] => Array
        (
            [0] => Rosuvastatina
        )

    [post_content_formatted] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:
Rosuvast 5 mg: Rosuvastatina 5 mg

Rosuvast 10 mg: Rosuvastatina 10 mg

Rosuvast 20 mg: Rosuvastatina 20 mg

Rosuvast 40 mg: Rosuvastatina 40 mg
Acción Terapéutica:
Inhibidor de la HMG-CoA reductasa.
Indicaciones:

Hiperlipidemia y dislipidemia mixta.
Pacientes pediátricos de 10 a 17 años de edad con hipercolesterolemia familiar heterocigótica.
Hipertrigliceridemia.
Disbetalipoproteinemia primeria ( Hiperlipoproteinemia tipo III).
Hipercolesterolemia familiar homocigota.
Retraso de la progresión de la aterosclerosis.
Prevención de eventos cardiovasculares.

Presentaciones:
Rosuvast 5 mg: Envases por 28, 30 y 60 comp. rec.

Rosuvast 10 mg: Envases por 28, 30, 56 y 60 comp. rec.

Rosuvast 20 mg:Envases por 28, 30 y 60 comp. rec.

Rosuvast 40 mg: Envases por 28 y 30 comp. rec.

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/ROSUVAST-prospecto.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:5:"sizes";a:3:{s:4:"full";a:4:{s:4:"file";s:26:"ROSUVAST-prospecto-pdf.jpg";s:5:"width";i:806;s:6:"height";i:882;s:9:"mime-type";s:10:"image/jpeg";}s:6:"medium";a:4:{s:4:"file";s:34:"ROSUVAST-prospecto-pdf-274x300.jpg";s:5:"width";i:274;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:9:"thumbnail";a:4:{s:4:"file";s:34:"ROSUVAST-prospecto-pdf-137x150.jpg";s:5:"width";i:137;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}}}
        )

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2021/07/ROSUVAST-informacion-para-el-paciente_.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:5:"sizes";a:4:{s:4:"full";a:4:{s:4:"file";s:46:"ROSUVAST-informacion-para-el-paciente_-pdf.jpg";s:5:"width";i:443;s:6:"height";i:6413;s:9:"mime-type";s:10:"image/jpeg";}s:6:"medium";a:4:{s:4:"file";s:53:"ROSUVAST-informacion-para-el-paciente_-pdf-21x300.jpg";s:5:"width";i:21;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:5:"large";a:4:{s:4:"file";s:54:"ROSUVAST-informacion-para-el-paciente_-pdf-71x1024.jpg";s:5:"width";i:71;s:6:"height";i:1024;s:9:"mime-type";s:10:"image/jpeg";}s:9:"thumbnail";a:4:{s:4:"file";s:53:"ROSUVAST-informacion-para-el-paciente_-pdf-10x150.jpg";s:5:"width";i:10;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}}}
        )

)

anexo_congre_single